Search research articles
Contact Us
Filters
Showing results (1291-1300 of 1,359) with videos related to
Page
of 136
Sort By:
British Journal of Haematology
|
June 29, 2005
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
G S Nowakowski, G W Dewald, J D Hoyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R Gerstner, Zheng Zhang, James R Fink, et al.
Journal of Parkinson'S Disease
|
April 18, 2022
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait
Joshua N Strelow, Juan C Baldermann, Till A Dembek, et al.
JAMA Network Open
|
January 18, 2024
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial
Stefanie T Jost, Salima Aloui, Julian Evans, et al.
Brain Stimulation
|
April 16, 2018
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
Haidar Salimi Dafsari, Jan Niklas Petry-Schmelzer, K Ray-Chaudhuri, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Scientific Reports
|
September 8, 2018
Predicting IDH genotype in gliomas using FET PET radiomics
Philipp Lohmann, Christoph Lerche, Elena K Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 19, 2017
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
Haidar S Dafsari, Paul Reker, Lisa Stalinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Jurij Rosen, Garry Ceccon, Elena K Bauer, et al.
Page
of 136
Search research articles
Search
Showing results (1291-1300 of 1,359) with videos related to
Sort By:
Page
of 136
British Journal of Haematology
|
June 29, 2005
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
G S Nowakowski, G W Dewald, J D Hoyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R Gerstner, Zheng Zhang, James R Fink, et al.
Journal of Parkinson'S Disease
|
April 18, 2022
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait
Joshua N Strelow, Juan C Baldermann, Till A Dembek, et al.
JAMA Network Open
|
January 18, 2024
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial
Stefanie T Jost, Salima Aloui, Julian Evans, et al.
Brain Stimulation
|
April 16, 2018
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
Haidar Salimi Dafsari, Jan Niklas Petry-Schmelzer, K Ray-Chaudhuri, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Scientific Reports
|
September 8, 2018
Predicting IDH genotype in gliomas using FET PET radiomics
Philipp Lohmann, Christoph Lerche, Elena K Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 19, 2017
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
Haidar S Dafsari, Paul Reker, Lisa Stalinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Jurij Rosen, Garry Ceccon, Elena K Bauer, et al.
Page
of 136